SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (645)9/27/1999 11:58:00 AM
From: Scripts  Read Replies (1) | Respond to of 1321
 
A 2 for 1 split at this time seems perfect. Those who have supported the company through its "early years" are going to be rewarded once the US Gov gives the OK. The more I think of a $1200 cost to avoid blindness ( I'm now in the age range where this is an increasing concern) the cheaper it seems. Much of the industrialised world will pay for the treatment via national health care programs (it will be a trivial cost) and QLT should flourish.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News